跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
谷安光 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Amino Acids (15) and Dipeptides (2) Injection
Approved
化学药品
Compound Amino Acids (15) and Dipeptides (2) Injection
Fresenius Kabi Austria Gmbh
🇨🇳 National Medical Products Administration
Approval Date
Sep 2, 2022
Approval ID
8JXPp9mD9JV
Company
Fresenius Kabi Austria Gmbh
Type
化学药品
Approval Details
Approval Id
8JXPp9mD9JV
Approval Number
国药准字HJ20181020
Generic Name
复方氨基酸(15)双肽(2)注射液
Generic Name En
Compound Amino Acids (15) and Dipeptides (2) Injection
Trade Name
谷安光
Drug Type
化学药品
Dosage Form
注射剂
Strength
1000ml: 134g (氨基酸/双肽)
Reg Date
2022-09-02
Expired Date
2027-09-01
Company Name
Fresenius Kabi Austria Gmbh
Production Company Name
Fresenius Kabi Austria Gmbh
Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Production Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 2, 2022
Approval ID
8JXPp9mD9JV
Type
化学药品
Back to NMPA Approvals
